#POLB Poolbeg Pharma – GMP manufacturing contract signed

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, announces an update on its lead asset, POLB 001, a small molecule immunomodulator which aims to address a significant unmet need in severe influenza. The Company has signed a contract for GMP […]

#TM1 Technology Minerals – Appointment of Chief Financial Officer

Technology Minerals Plc (LSE: TM1), the first UK company focused on creating a sustainable circular economy for battery metals, is pleased to announce the appointment of James Cable as a director and Chief Financial Officer (“CFO”) of the Company with immediate effect.   James has extensive experience of investment evaluation and financial transformation across several industries, […]

#BRES Blencowe Resources – Investor Evening – Thursday 12 May 2022

Blencowe Resources would be pleased to welcome current shareholders and potential investors to an Investor Evening on Thursday 12 May 2022 in the City of London. The event will take place from 6pm for a 6:30pm start in The Partner Room at The Counting House, 50 Cornhill, EC3V 3PD – this is close to Bank […]

#TM1 Technology Minerals – Proposed Sale of 10% Interest in US Projects

Technology Minerals (LSE: TM1), the first listed UK company focused on creating a sustainable circular economy for battery metals, announces that it has signed a Memorandum of Understanding (“MOU”) for the Proposed Sale (“Proposed Sale”) of an initial 10 per cent interest in the Company’s registered claims in its wholly owned US cobalt/copper projects; the Blackbird […]

#POW Power Metal Resources – Ditau Project – Exploration Programme Expansion

Power Metal Resources plc (LON:POW),  the London listed exploration company seeking large-scale metal discoveries across its global project portfolio, announces an update from the Ditau Camp Project (“Ditau” or the “Project”) located in southwest Botswana which is prospective for carbonatite hosted rare-earth element (“REE”) and base-metal mineralisation. Ditau is held within a 50/50 Joint Venture (“Kanye Resources”) with […]

#KAV Kavango Resources – Ditau exploration programme expansion

Following completion of hole DITDD003, Kavango Resources plc (LSE:KAV) has expanded the exploration programme at its Ditau project in south west Botswana. Kavango is exploring for rare earth elements (“REEs”) and base metal mineralisation at Ditau. Hole DITDD003 was drilled into the i10 Target. The expanded exploration programme will include an additional 16.1km of new Audio-Magnetotelluric […]

#ORPH Open Orphan – Vaccine field study contract

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO , a subsidiary of Open Orphan, has been awarded a new study with an existing Big Pharma client to act as a vaccination site for a Phase […]